This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Brookfield/GIG’s Genesee & Wyoming acquisition receives Australian approval, with undertakings

( November 15, 2019, 01:10 GMT | Official Statement) -- MLex Summary: Brookfield Infrastructure Group’s offer to offload its stake in Genesee & Wyoming Australia to appease Australian regulators in their review Brookfield’s global plans to acquire Genesee & Wyoming has been accepted, with the watchdog announcing today it wouldn’t oppose the deal. In an entry on its website, the Australian Competition & Consumer Commission said its review of the undertakings’ impact on the bid for Genesee & Wyoming by Brookfield and partner GIC Special Investment, Singapore's sovereign wealth fund, had enabled it to clear the deal. The proposed undertakings, published today, also include a commitment to “maintain the economic viability, marketability, competitiveness and goodwill of the divestiture business prior to divestiture.”ACCC website entry follows; public version of undertakings is attached. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections